Ledger.Open graph →
SEC Form D · filed November 10, 2010

Kala Pharmaceuticals, Inc

Offering
$3.0M
Sold
$3.0M
Exemption
—
Industry
Biotechnology
Location
WALTHAM, MA
Type
—

People & firms on this filing (7)

Robert Tepper · Cambridge, MADirectorRobert Langer · Bedford, MADirectorRobert Paull · New York, NYExec · DirectorKevin Bitterman · Waltham, MADirectorRobert Tepper · Newton, MADirectorJustin Hanes · Baltimore, MDDirectorRobert Langer · PITTSBURGH, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗